MEI Pharma (Formerly Marshall Edwards)
Innovative oncology therapies targeting unmet medical needs in cancer treatment. Learn more
Launch date
Employees
Market cap
AUD31.5m
Enterprise valuation
(AUD38m) (Public information from Sep 2024)
Share price
$3.14 MEIP
San Diego California (HQ)
Authorizing premium user...